Low Levels of Mannan-Binding Lectin or Ficolins Are Not Associated with an Increased Risk of Cytomegalovirus Disease in HIV-Infected Patients

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Egli, Adrian ^a,b,g   Schäfer, Juliane ^c   Osthoff, Michael ^b   Thiel, Steffen ^d   Mikkelsen, Christina ^d   Rauch, Andri ^e   Hirsch, Hans H ^a,f   Bucher, Heiner C ^c   Young, James ^c   Jensenius, Jens C ^d   Battegay, Manuel ^a   Trendelenburg, Marten ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d AARHUS UNIVERSITY   (Denmark)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FICOLIN; FICOLIN H TYPE; FICOLIN L TYPE; FICOLIN M TYPE; MANNAN BINDING LECTIN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENOTYPE; H FICOLIN GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; L FICOLIN GENE; M FICOLIN GENE; MAJOR CLINICAL STUDY; MALE; MBL GENE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE STUDY; RISK REDUCTION; SEROPREVALENCE;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HIV; HIV INFECTIONS; HUMANS; LECTINS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; RISK FACTORS;

CYTOMEGALOVIRUS;

EID: 84871881603     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051983     Document Type: Article

References (55)

1. Gandhi MK, Khanna R, (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis 4: 725-738.
2. Ljungman P, Griffiths PD, Paya CV, (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34: 1094-1097.
3. Battegay M, Nuesch R, Hirschel B, Kaufmann GR, (2006) Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 6: 280-287.
4. Tay-Kearney ML, Enger C, Semba RD, Royal W 3rd, Dunn JP, et al (1997) T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients. J Infect Dis 176: 790-794.
5. Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, et al. (2005) Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. J Infect Dis 191: 873-880.
6. Jabs DA (2011) Cytomegalovirus retinitis and the acquired immunodeficiency syndrome-bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol 151: 198-216 e191.
7. Singh KP, Howard JL, Wild SP, Jones SL, Hoy J, et al. (2007) Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery. Clin Immunol 124: 200-206.
8. Jacobson MA, Tan QX, Girling V, Poon C, Van Natta M, et al. (2008) Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis 46: 458-466.
9. Benko DM, Gibson W, (1986) Primate cytomegalovirus glycoproteins: lectin-binding properties and sensitivities to glycosidases. J Virol 59: 703-713.
10. Brown KS, Keogh MJ, Owsianka AM, Adair R, Patel AH, et al. (2010) Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry. Protein Cell 1: 664-674.
11. Kase T, Suzuki Y, Kawai T, Sakamoto T, Ohtani K, et al. (1999) Human mannan-binding lectin inhibits the infection of influenza A virus without complement. Immunology 97: 385-392.
12. Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA, (1989) A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 169: 185-196.
13. Ip WK, Chan KH, Law HK, Tso GH, Kong EK, et al. (2005) Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 191: 1697-1704.
14. Stoermer KA, Morrison TE, (2011) Complement and viral pathogenesis. Virology 411: 362-373.
15. Thielens NM, Tacnet-Delorme P, Arlaud GJ, (2002) Interaction of C1q and mannan-binding lectin with viruses. Immunobiology 205: 563-574.
16. Cervera C, Lozano F, Saval N, Gimferrer I, Ibanez A, et al. (2007) The influence of innate immunity gene receptors polymorphisms in renal transplant infections. Transplantation 83: 1493-1500.
17. Wu W, Chen Y, Qiao H, Tao R, Gu W, et al. (2012) Human mannose-binding lectin inhibits human cytomegalovirus infection in human embryonic pulmonary fibroblast. APMIS 120: 675-682.
18. Spiller OB, Morgan BP, (1998) Antibody-independent activation of the classical complement pathway by cytomegalovirus-infected fibroblasts. J Infect Dis 178: 1597-1603.
19. Garlatti V, Belloy N, Martin L, Lacroix M, Matsushita M, et al. (2007) Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J 26: 623-633.
20. Liu Y, Endo Y, Iwaki D, Nakata M, Matsushita M, et al. (2005) Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 175: 3150-3156.
21. O'Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S, (2011) A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection. PLoS One 6: e17377.
22. Somnuke P, Hauhart RE, Atkinson JP, Diamond MS, Avirutnan P, (2011) N-linked glycosylation of dengue virus NS1 protein modulates secretion, cell-surface expression, hexamer stability, and interactions with human complement. Virology 413: 253-264.
23. Cummings KL, Waggoner SN, Tacke R, Hahn YS, (2007) Role of complement in immune regulation and its exploitation by virus. Viral Immunol 20: 505-524.
24. Herpers BL, Endeman H, de Jong BA, de Jongh BM, Grutters JC, et al. (2009) Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes. Clin Exp Immunol 156: 488-494.
25. Perez-Castellano M, Penaranda M, Payeras A, Mila J, Riera M, et al. (2006) Mannose-binding lectin does not act as an acute-phase reactant in adults with community-acquired pneumococcal pneumonia. Clin Exp Immunol 145: 228-234.
26. Garred P, Thiel S, Madsen HO, Ryder LP, Jensenius JC, et al. (1992) Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol 90: 517-521.
27. Super M, Gillies SD, Foley S, Sastry K, Schweinle JE, et al. (1992) Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet 2: 50-55.
28. Garred P, Honore C, Ma YJ, Munthe-Fog L, Hummelshoj T, (2009) MBL2, FCN1, FCN2 and FCN3-The genes behind the initiation of the lectin pathway of complement. Mol Immunol 46: 2737-2744.
29. de Rooij BJ, van der Beek MT, van Hoek B, Vossen AC, Rogier Ten Hove W, et al. (2011) Mannose-binding lectin and Ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation. J Hepatol 55: 800-807.
30. Gadjeva M, Paludan SR, Thiel S, Slavov V, Ruseva M, et al. (2004) Mannan-binding lectin modulates the response to HSV-2 infection. Clin Exp Immunol 138: 304-311.
31. Manuel O, Pascual M, Trendelenburg M, Meylan PR, (2007) Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation 83: 359-362.
32. Osthoff M, Rovo A, Stern M, Danner D, Gratwohl A, et al. (2010) Mannose-binding lectin levels and major infections in a cohort of very long-term survivors after allogeneic stem cell transplantation. Haematologica 95: 1389-1396.
33. Seppanen M, Lokki ML, Lappalainen M, Hiltunen-Back E, Rovio AT, et al. (2009) Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection. Hum Immunol 70: 218-221.
34. Cervera C, Lozano F, Linares L, Anton A, Balderramo D, et al. (2009) Influence of mannose-binding lectin gene polymorphisms on the invasiveness of cytomegalovirus disease after solid organ transplantation. Transplant Proc 41: 2259-2261.
35. Sagedal S, Thiel S, Hansen TK, Mollnes TE, Rollag H, et al. (2008) Impact of the complement lectin pathway on cytomegalovirus disease early after kidney transplantation. Nephrol Dial Transplant 23: 4054-4060.
36. Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Gunthard HF, et al. (2010) Cohort profile: the Swiss HIV Cohort study. Int J Epidemiol 39: 1179-1189.
37. Lubin JH, Gail MH, (1984) Biased selection of controls for case-control analyses of cohort studies. Biometrics 40: 63-75.
38. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC, (2010) Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun 2: 167-180.
39. Henckaerts L, Nielsen KR, Steffensen R, Van Steen K, Mathieu C, et al. (2009) Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med 37: 192-201, e191-193.
40. Breslow N, (1982) Covariance adjustment of relative-risk estimates in matched studies. Biometrics 38: 661-672.
41. Lachin JM, (2008) Sample size evaluation for a multiply matched case-control study using the score test from a conditional logistic (discrete Cox PH) regression model. Stat Med 27: 2509-2523.
42. Sarkar N (2008) Lattice: Multivariate Data Visualization with R. New York: Springer.
43. Hu Y, Wu D, Tao R, Shang S, (2010) Association between mannose-binding lectin gene polymorphism and pediatric cytomegalovirus infection. Viral Immunol 23: 443-447.
44. Szala A, Paradowska E, Nowakowska D, Swierzko AS, Dzierzanowska-Fangrat K, et al. (2011) Mannan-binding lectin-2 (MBL2) gene polymorphisms in prenatal and perinatal cytomegalovirus infections. Mol Immunol 48: 2203-2206.
45. Kwakkel-van Erp JM, Paantjens AW, van Kessel DA, Grutters JC, van den Bosch JM, et al. (2011) Mannose-binding lectin deficiency linked to cytomegalovirus (CMV) reactivation and survival in lung transplantation. Clin Exp Immunol 165: 410-416.
46. Worthley DL, Johnson DF, Eisen DP, Dean MM, Heatley SL, et al. (2009) Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation. Clin Infect Dis 48: 410-417.
47. Bouwman LH, Roos A, Terpstra OT, de Knijff P, van Hoek B, et al. (2005) Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation. Gastroenterology 129: 408-414.
48. Fiane AE, Ueland T, Simonsen S, Scott H, Endresen K, et al. (2005) Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation. Eur Heart J 26: 1660-1665.
49. Egli A, Bergamin O, Mullhaupt B, Seebach JD, Mueller NJ, et al. (2008) Cytomegalovirus-associated chorioretinitis after liver transplantation: case report and review of the literature. Transpl Infect Dis 10: 27-43.
50. Chow SP, Dean MM, Depla JA, Daniell MD, Eisen DP, (2011) Mannose-binding lectin as part of the complement pathway: characterization in non-inflamed and inflamed human eyes. Clin Experiment Ophthalmol 39: 871-877.
51. Deayton JR, (2000) Is cytomegalovirus viraemia a useful tool in managing CMV disease? Sex Transm Infect 76: 342-344.
52. Cunha AA, Aquino VH, Mariguela V, Nogueira ML, Figueiredo LT, (2011) Evaluation of glycoprotein B genotypes and load of CMV infecting blood leukocytes on prognosis of AIDS patients. Rev Inst Med Trop Sao Paulo 53: 82-88.
53. Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN, (2007) CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection- a retrospective autopsy based study. BMC Infect Dis 7: 127.
54. Jeon S, Lee WK, Lee Y, Lee DG, Lee JW, (2012) Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation. Ophthalmology 119: 1892-1898.
55. Egli A, Humar A, Kumar D, (2012) State-of-the-art on Monitoring of Cytomegalovirus-Specific Cell Mediated Immunity after Organ Transplant: A Primer for the Clinician. Clin Infect Dis 55(12): 1678-1689.